(Q40713483)

23 September 2017

title

Adiponectin is required for cardiac MEF2 activation during pressure overload induced hypertrophy (English)

1 reference

23 September 2017

Keith Dadson

1

1 reference

23 September 2017

Subat Turdi

2

1 reference

23 September 2017

Sarah Hashemi

3

1 reference

23 September 2017

Jianzhong Zhao

4

1 reference

23 September 2017

Nazar Polidovitch

5

1 reference

23 September 2017

Sanja Beca

6

1 reference

23 September 2017

Peter H Backx

7

1 reference

23 September 2017

John C McDermott

8

1 reference

23 September 2017

Gary Sweeney

9

1 reference

23 September 2017

publication date

18 July 2015

1 reference

Journal of Molecular and Cellular Cardiology

23 September 2017

published in

1 reference

23 September 2017

volume

86

1 reference

23 September 2017

page(s)

102-109

1 reference

Cardiac-specific elevations in thyroid hormone enhance contractility and prevent pressure overload-induced cardiac dysfunction

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.06.020

The primary benefits of angiotensin-converting enzyme inhibition on cardiac remodeling occur during sleep time in murine pressure overload hypertrophy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.06.020

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.06.020

Cardiac remodeling in obesity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.06.020

Pathological ventricular remodeling: mechanisms: part 1 of 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.06.020

Direct effects of adipokines on the heart: focus on adiponectin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.06.020

Adiponectin protects against the development of systolic dysfunction following myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.06.020

Adiponectin-mediated modulation of hypertrophic signals in the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.06.020

Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.06.020

Globular adiponectin inhibits angiotensin II-induced nuclear factor kappaB activation through AMP-activated protein kinase in cardiac hypertrophy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.06.020

Endogenously produced adiponectin protects cardiomyocytes from hypertrophy by a PPARgamma-dependent autocrine mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.06.020

Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.06.020

ω-3 Polyunsaturated fatty acids prevent pressure overload-induced ventricular dilation and decrease in mitochondrial enzymes despite no change in adiponectin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.06.020

Effects of adiponectin deficiency on structural and metabolic remodeling in mice subjected to pressure overload

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.06.020

Role of adiponectin in the development of high fat diet-induced metabolic abnormalities in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.06.020

Temporal and Molecular Analyses of Cardiac Extracellular Matrix Remodeling following Pressure Overload in Adiponectin Deficient Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.06.020

HRC is a direct transcriptional target of MEF2 during cardiac, skeletal, and arterial smooth muscle development in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.06.020

Myocardin is a direct transcriptional target of Mef2, Tead and Foxo proteins during cardiovascular development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.06.020

MEF2: a central regulator of diverse developmental programs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.06.020

The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.06.020

Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.06.020

Phosphorylation motifs regulating the stability and function of myocyte enhancer factor 2A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.06.020

Protein kinase A represses skeletal myogenesis by targeting myocyte enhancer factor 2D.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.06.020

Myocyte enhancer factor 2 acetylation by p300 enhances its DNA binding activity, transcriptional activity, and myogenic differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.06.020

SUMO-1 modification of MEF2A regulates its transcriptional activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.06.020

Cross-talk between glycogen synthase kinase 3β (GSK3β) and p38MAPK regulates myocyte enhancer factor 2 (MEF2) activity in skeletal and cardiac muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.06.020

Regulation of MEF2 by p38 MAPK and its implication in cardiomyocyte biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.06.020

Globular and full-length forms of adiponectin mediate specific changes in glucose and fatty acid uptake and metabolism in cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.06.020

Diet-induced insulin resistance in mice lacking adiponectin/ACRP30

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.06.020

The ShcA phosphotyrosine docking protein uses distinct mechanisms to regulate myocyte and global heart function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.06.020

Temporal analysis of mechanisms leading to stimulation of glucose uptake in skeletal muscle cells by an adipokine mixture derived from primary rat adipocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.06.020

Adiponectin corrects high-fat diet-induced disturbances in muscle metabolomic profile and whole-body glucose homeostasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.06.020

Signaling mechanisms underlying the insulin-sensitizing effects of adiponectin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.06.020

APPL1 mediates adiponectin-stimulated p38 MAPK activation by scaffolding the TAK1-MKK3-p38 MAPK pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.06.020

Regulation of cardiomyocyte Glut4 expression by ZAC1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.06.020

Mechanisms regulating GLUT4 transcription in skeletal muscle cells are highly conserved across vertebrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.06.020

Glucose transport in the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.06.020

Cardiac metabolism in heart failure: implications beyond ATP production.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.06.020

The positive transcription elongation factor b is an essential cofactor for the activation of transcription by myocyte enhancer factor 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.06.020

Structure of p300 bound to MEF2 on DNA reveals a mechanism of enhanceosome assembly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.06.020

p38 MAPK signaling regulates recruitment of Ash2L-containing methyltransferase complexes to specific genes during differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.06.020

Heterogeneous myocyte enhancer factor-2 (Mef2) activation in myocytes predicts focal scarring in hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.06.020

Adiponectin mediated APPL1-AMPK signaling induces cell migration, MMP activation, and collagen remodeling in cardiac fibroblasts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.06.020

Gender difference in the impact of type 2 diabetes on coronary heart disease risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.06.020

Sex differences in SR Ca(2+) release in murine ventricular myocytes are regulated by the cAMP/PKA pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.06.020

10.1016/J.YJMCC.2015.06.020

7 January 2021

Identifiers

DOI

1 reference

23 September 2017

1 reference